Search Result "radioimmunotherapy"


The ARRONAX Project

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 3 Year: 2011 Page: 186-196
Author(s): Ferid Haddad, Jacques Barbet, Jean-Francois Chatal

Patient-Specific Alpha-Particle Dosimetry

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 4 Year: 2011 Page: 329-335
Author(s): Stig Palm, Jorgen Elgqvist, Lars Jacobsson

Modelling and Dosimetry for Alpha-Particle Therapy

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 3 Year: 2011 Page: 261-265
Author(s): George Sgouros, Robert F. Hobbs, Hong Song

Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 4 Year: 2011 Page: 283-294
Author(s): Ganesan Vaidyanathan, Michael R. Zalutsky

PET Tracers Based on 86Y

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 2 Year: 2011 Page: 122-130
Author(s): Jinming Huang, Liyang Cui, Fan Wang, Zhaofei Liu

Alpha-Particle Microdosimetry

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 3 Year: 2011 Page: 266-280
Author(s): Nicolas Chouin, Manuel Bardies

Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 319-327
Author(s): Ticiana Leal, Julie E. Chang, Minesh Mehta, H. Ian Robins

The Development of Copper Radiopharmaceuticals for Imaging and Therapy

Journal: Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2011 Page: 413-429
Author(s): Monica Shokeen, Thaddeus J. Wadas

Chelating Agents and their Use in Radiopharmaceutical Sciences

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 968-983
Author(s): B. Wangler, R. Schirrmacher, P. Bartenstein, C. Wangler

Astatine-211: Production and Availability

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 3 Year: 2011 Page: 177-185
Author(s): Michael R. Zalutsky, Marek Pruszynski

Previous   Next

Go To   Results 11 - 20 of 45

Filter Result

Volume Year
Content Type
Ads
© 2023 Bentham Science Publishers | Privacy Policy